Your browser doesn't support javascript.
loading
HNRNPAB-regulated lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
Yang, Yi; Chen, Qing; Piao, Hai-Yan; Wang, Biao; Zhu, Gui-Qi; Chen, Er-Bao; Xiao, Kun; Zhou, Zheng-Jun; Shi, Guo-Ming; Shi, Ying-Hong; Wu, Wei-Zhong; Fan, Jia; Zhou, Jian; Dai, Zhi.
Afiliación
  • Yang Y; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen Q; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Piao HY; Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China.
  • Wang B; Department of General Surgery, Zhongshan Hospital (South), Fudan University, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Zhu GQ; Medical Oncology Department of Gastrointestinal cancer, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
  • Chen EB; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xiao K; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Zhou ZJ; Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China.
  • Shi GM; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Shi YH; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Wu WZ; Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China.
  • Fan J; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Zhou J; State Key Laboratory of Genetic Engineering, Fudan University, Shanghai, China.
  • Dai Z; Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai, China.
Int J Cancer ; 146(1): 169-180, 2020 01 01.
Article en En | MEDLINE | ID: mdl-31090062

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Ribonucleoproteína Heterogénea-Nuclear Grupo A-B / ARN Largo no Codificante / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Ribonucleoproteína Heterogénea-Nuclear Grupo A-B / ARN Largo no Codificante / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: China